医学新知2025，Vol.35Issue(5)：544-552,9.DOI:10.12173/j.issn.1004-5511.202308002
《矮小症临床路径(2019年版)》的临床适用性调查
Clinical applicability survey of the Clinical Pathway for Short Stature(2019 Edition)
摘要
Abstract
Objective To investigate the clinical applicability of the Clinical Pathway for Short Stature(2019 Edition).Methods A cross-sectional survey was conducted among pediatric endocrinologists using a questionnaire adapted from the guideline clinical applicability evaluation tool.Descriptive analysis was performed on the basic characteristics of respondents,dimensional scores,pathways of access,and factors influencing implementation.Kruskal-Wallis rank-sum test and Nemenyi test were used for multiple and pairwise comparisons.Multiple linear regression analysis combined with stepwise regression was used to analyze factors influencing the scores.Results A total of 206 valid questionnaires were collected.The mean and median scores for all dimensions and overall evaluation of the clinical pathway for short stature were ≤75 points.The median scores for acceptability,readability,feasibility,accessibility,and overall evaluation were 75.00,62.50,62.50,50.00,and 75.00,respectively.Eighteen percent of the survey respondents believed that there were implementation barriers to the clinical pathway,including factors related to medical staff,patients,the environment,and the clinical pathway itself.Multiple comparisons and multiple linear regression analysis showed that familiarity with the clinical pathway was the main influencing factor for the scores(P＜0.05).Conclusion There is significant room for improvement in the applicability of the clinical pathway for short stature in China.Efforts in promoting,training,and disseminating the clinical pathway need to be enhanced,and implementation requires stronger support in terms of environment and technology.关键词
矮小症/临床路径/适用性/问卷调查Key words
Short stature/Clinical pathway/Applicability/Questionnaire survey分类
临床医学引用本文复制引用
肖琳琪,冯佳佳,潘慧,罗小平,巩纯秀,张潘,张瑜,韩勇,林丽开..《矮小症临床路径(2019年版)》的临床适用性调查[J].医学新知,2025,35(5):544-552,9.基金项目
国家医疗保障局委托项目(20220314) （20220314）
